Epidemiology of Infectious Diseases: Outbreak Surveillance and Emergency Response
Infectious diseases have posed a significant threat to human health throughout history. From the plague of the 14th century to more recent outbreaks of Ebola, SARS and COVID-19, infectious diseases have demonstrated their ability to spread rapidly, resulting in significant morbidity and mortality. The importance of outbreak surveillance and emergency response in battling infectious diseases is increasingly clear as the globe grapples with new disease outbreaks and potential pandemics. The backbone of epidemic response is surveillance, which functions similarly to a radar system constantly scanning for possible threats. Surveillance systems are comprehensive frameworks and processes that employ a variety of tools and technologies to gather, analyze, and manage health-related data in order to follow disease patterns, reveal unusual clusters of occurrences, and detect early warning signs (World Health Organization, 2022).
Staying Watchful: The Role of Outbreak Surveillance in Infectious Disease Control
Outbreak surveillance serves as a skilled detective in the field of infectious diseases, diligently gathering, analyzing, and interpreting health-related data from various sources within a population. This enables the monitoring of disease occurrence and transmission, detecting outbreaks, assessing public health risks, and formulating suitable responses to safeguard and advance public health (World Health Organization, 2022). Surveillance can take numerous forms, including passive surveillance, in which healthcare professionals report instances to health authorities; and active surveillance, which is a proactive scientific endeavor that systematically searches for prospective cases in order to provide a complete understanding of disease prevalence. This critical process enables for early diagnosis of an epidemic, which is required for a timely response (Murray & Cohen, 2017; Soucie, 2012). In late 2013, an Ebola virus disease epidemic was reported in Guinea, West Africa. Systems for monitoring outbreaks rapidly identified the odd illness pattern and the information collected through surveillance indicated an outbreak that was quickly intensifying and had already reached the nearby countries of Sierra Leone and Liberia (McNamara et al., 2016). Early notice of international health organizations rendered it possible for a planned multinational response. Public health organizations, such as the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO), mobilised resources and sent workforce to the afflicted nations. Facilities for isolation were set up, and contact tracking operations started right away (McNamara et al., 2016; Woolhouse et al., 2015). Additionally, real-time monitoring data also contributed to the implementation of infection prevention plans and community outreach programs that increased public health awareness. Despite the outbreak's catastrophic consequences, which included over 11,000 confirmed fatalities, early detection-related actions allowed to curtail the spread of the outbreak, halting further widespread transmission (Sarukhan, 2016). This occurrence emphasizes the vital significance of outbreak surveillance in recognizing and controlling emerging infectious illnesses and its pivotal role in safeguarding global health (McNamara et al., 2016; Reece et al., 2017).
Fast forward to December 2019, when Wuhan, China had an unusual cluster of patients with pneumonia of unknown cause. Epidemic surveillance systems, like a scientific sentinel, responded rapidly to the warning of an oncoming pandemic (Zhu et al., 2020). Epidemiologists tracked the course of the disease and assessed its impact on different groups using real-time data. Public health surveillance drove global health authorities to undertake targeted responses by monitoring the disease's progress and analyzing its impact on different populations. Through outbreak surveillance, it was possible to understand the unique virus's epidemiology, including its modes of transmission, period of incubation, and clinical symptoms (Ellwanger et al., 2019; Khan, 2013). Travel restrictions, quarantine procedures, and mass testing campaigns were all put into place by international health authorities using the information gathered through epidemic surveillance. The timely discovery of the new coronavirus and the ongoing monitoring of COVID-19 cases have been crucial in directing public health actions around the globe, including the creation and distribution of vaccinations to halt the pandemic. These actions have been crucial for slowing the spread of the disease and, more importantly, in preventing the collapse of many countries' healthcare systems (Bou-Karroum et al., 2021).
Sentinels of Safety: Public Health Surveillance Systems in Action
Public health surveillance enables the early detection of infectious disease outbreaks by monitoring the emergence of new diseases and identifying unusual trends or increases in disease incidence. Surveillance systems can be designed to track specific infectious agents, symptoms, or syndromes to quickly identify potential outbreaks (European Commission, n.d.; Jia et al., 2023). To monitor disease trends and detect odd disease patterns, public health surveillance relies on diverse data sources such as hospital records, laboratory reports, and digital data, much like a network of weather radars examining the environment for approaching storms. It continually scans for clusters of newly emerging infectious diseases, much like a weather radar on high alert. A disease cluster is the occurrence of a greater number of instances of a given disease or health condition within a specified geographic area or population and in excess of what would normally be anticipated. The timely identification of infectious illnesses through outbreak monitoring is critical, particularly for diseases with short incubation periods or high transmission rates. Failure to promptly recognize cases can lead to a rapid surge in infections (Green & Kaufman, 2002; World Health Organization, 2014). Rapid identification enables health authorities to take immediate action, implement control measures and prevent further transmission.
Real-world examples include the Global Influenza Surveillance and Response System (GISRS), a global network established by the WHO, acting as a universal observatory for such viruses (Hay & McCauley, 2018). This system monitors, collects and analyses influenza virus samples from around the world and provides early warning of possible pandemic variants. In addition, the Global Public Health Intelligence Network (GPHIN), which functions like a digital surveillance satellite, searches press releases and media reports from around the world for disease indicators (Mykhalovskiy & Weir, 2006). The early detection of the COVID-19 epidemic in Wuhan and the subsequent notification of health authorities worldwide were both made possible by GPHIN (Budd et al., 2020). Another example is the WHO's Global Outbreak Alert and Reaction Network (GOARN), a collaboration of technical organizations, research institutions, universities, and global health entities working together to respond globally to infectious disease outbreaks. GOARN embarked on a capacity-building journey, leveraging the unique strengths of more than 250 partner institutions, based on the premise that no single institution can provide all the expertise needed to effectively respond to an intricate public health emergency nor meet all the training requirements for outbreak response. GOARN serves as an emergency response force, quickly mobilizing experts and resources from around the world to fight epidemics, and has proven particularly successful in containing the spread of Ebola in West Africa (Christensen et al., 2021; Mackenzie et al., 2014) .
Pillars of Outbreak Response: A Systematic Approach to Containing Infectious Threats
Diagnostic Testing: Pinpointing the Culprit
Diagnosis is a cornerstone of effective outbreak control, as early identification of infected individuals allows for immediate intervention, containment and prevention of further spread. Early diagnosis allows public health authorities to quickly deploy targeted strategies to mitigate the public health burden of outbreaks (Institute of Medicine (US) Committee on Emerging Microbial Threats to Health in the 21st Century, 2003). Infectious illness outbreaks are detected and confirmed using a variety of diagnostic techniques and technologies, including molecular testing, serological testing, and imaging, all of which are essential for establishing the presence of the infectious agent (Bohn et al., 2020; Machado et al., 2020). The polymerase chain reaction (PCR), a molecular diagnostic technique, allows for the precise identification of pathogen genetic material, allowing prompt and precise diagnosis. Serological tests, on the other hand, allow for detecting antibodies against the pathogen which reflect prior or ongoing infection or immunity against the disease. Widespread PCR testing enabled early identification and isolation of infected individuals, breaking chains of transmission in outbreak scenarios such as the COVID-19 pandemic (Kubina & Dziedzic, 2020; Tang et al., 1997).
Early detection of COVID-19-infected individuals proved to be a game changer in curbing the virus's spread in places that adopted mass testing procedures, such as South Korea. This strategy set a model for other nations and drastically reduced transmission. Without strict lockdown restrictions, South Korea managed to contain the spread by quickly identifying symptoms, infected individuals and tracing contacts (Hur & Kim, 2020). Another noteworthy instance is how Taiwan's quick action and early diagnostic efforts averted COVID-19 from spreading. The Taiwanese government used cutting-edge health technologies, including the “Taiwan Social Distancing App”, which tracked the distance between app users to prevent transmission of COVID-19. This social distancing software enabled real-time case monitoring and reporting of all contacts related to COVID-19 cases. As a result, Taiwan has kept its case count low and successfully illustrated the advantages of early diagnosis in outbreak management (Garrett et al., 2022; Liu, 2021). Remarkably, the importance of early disease detection goes well beyond the COVID-19 epidemic, as evidenced by the development of rapid tests for malaria, which have transformed disease management. These easy-to-use diagnostic methods have completely changed the way malaria is diagnosed in endemic areas, especially in remote regions where access to laboratories is limited. Early detection enables appropriate treatment, thereby reducing mortality and morbidity from malaria (Kavanaugh et al., 2021; Moody, 2002). Investments in reliable diagnostic approaches and easily accessible laboratory facilities are therefore essential for efficient outbreak response, as they pave the way to disrupting the chain of transmission, guide contact tracing efforts, and take immediate preventive action.
Tracing for Triumph: The Power of Contact Tracing in Disease Control
Contact tracing is an important strategy in epidemiology and refers to the identification and diagnosis of those who have been in contact with an infected person. The ultimate goal is to shorten the time it takes to detect and treat an infected patient and thus significantly minimize the risk of transmission to subsequent susceptible individuals (Hossain et al., 2022). With traditional manual contact tracing, qualified healthcare workers interview confirmed cases to gather information about their recent activities and interactions. However, as technology advances, digital contact tracing is growing in popularity (Barrat et al., 2021). Mobile applications and wearable devices can be used to track and alert those who have been in close proximity to confirmed cases. Applications like this often leverage Bluetooth technology to capture interactions between devices and sending exposure notifications when a user tests positive (Soldano et al., 2021). Real-world contact tracing success stories show how useful it is in fighting infectious diseases and saving lives. Smallpox, a life-threatening infectious disease, was effectively eradicated by a thorough strategy that included intensive contact tracing, quarantine, and phased vaccination programs. Smallpox cases were identified and isolated, and contacts closely monitored and vaccinated to prevent future spread. Smallpox was the first disease to be eradicated through human effort as a results of this strategy (Kerrod et al., 2005).
Masking for Protection: The Vital Role of Infection Prevention and Control Measures
Infection prevention and control (IPC) strategies constitute the first line of defense against the spread of infectious diseases, both in healthcare facilities and among the general population. These preventive measures include the correct use of personal protective equipment (PPE), strict hand hygiene guidelines, compliance with isolation and quarantine rules, and thorough cleaning and disinfection of the environment. A basic IPC practice that prevents the spread of disease from contaminated hands is routine hand washing with soap and water or the use of alcohol-based hand sanitizers (Loveday & Wilson, 2021; Wilson, 2021). Proper use of personal protective equipment (PPE) such as masks, gloves, gowns and face shields has also proved essential in preventing infection and transmission, particularly among healthcare professionals and other frontline workers who are at increased risk of pathogen exposure (Loveday & Wilson, 2021; Verbeek et al., 2020).
During the COVID-19 pandemic, everyone vividly recalls the widespread adoption of masks, especially indoors, as a mandatory measure to curb disease transmission. Although masks are not a stand-alone solution, they are a powerful tool when combined with other preventive measures such as social distancing and hand hygiene (Howard et al., 2021; Rahman et al., 2022). The significance of IPC measures, exemplified by the COVID-19 pandemic, is further underscored by the Sturgis Motorcycle Rally held in South Dakota in August 2020. With over 460,000 attendance, this rally transformed into a super spreader event, with most participants not wearing masks and not following social distancing norms. Researchers therefore connected the rally to more than 260,000 COVID-19 infections across several states, causing sizable epidemics (Camero, 2020). This incident is a stark reminder of the critical role IPC plays in containing infectious diseases and protecting public health.
Defeating Disease: The Victory of Vaccines and the Shield of Herd Immunity
Vaccination stands as a major triumph in modern medicine, offering long-term protection against infectious diseases and averting past epidemics. Mass immunization initiatives have played a pivotal role in eradicating diseases like smallpox and reducing the burden of measles and poliomielytis (Conis, 2019; Riedel, 2005; Saman et al., 2023). Vaccines improve the immune system's ability to fight off microorganisms, safeguarding against life-threatening diseases. Immunized individuals are not only less likely to develop severe disease but also to contract and spread infection, hence contributing to herd immunity (K B et al., 2022). Herd immunity, also known as community immunity, develops when a significant portion of a population develops immunity to a specific infectious pathogen either through vaccination or prior exposure. By reducing the chance of contracting the virus, herd immunity protects vulnerable people who cannot get vaccines, such as newborns or those with compromised immune systems, thus creating a protective barrier against disease transmission in the population (Ashby & Best, 2021). Herd immunity and vaccination are effective strategies, yet there are a myriad of obstacles standing in the way of their implementation. Herd immunity requires vaccinating a large proportion of the population, and any gaps in immunization coverage may threaten its effectiveness. Achievement of high immunization coverage can be hampered by immunization reluctance, disinformation and uneven access to vaccines. Rapid virus mutation can also impact vaccine efficacy throughout pandemics and implies the ongoing development of new and suitable vaccines (Nuwarda et al., 2022; She et al., 2022). Nevertheless, the rapid development of COVID-19 vaccines showcased the potential of scientific collaboration and vaccine technology. COVID-19-related vaccine hesitancy prompted the need for vaccine education and building trust to ensure broad vaccine acceptance. Despite the emergence of new virus variants, booster doses have been recommended to prolong immunity and counter evolving strains that have challenged vaccine effectiveness (Nuwarda et al., 2022).
Learning from History: Applying One Health for Enhanced Outbreak Control
Throughout history, infectious disease outbreaks have posed significant threats to global health, with the Spanish flu of 1918 and the COVID-19 pandemic being two of the most notable examples. Despite breakthroughs in modern science and technology, the COVID-19 pandemic unearthed numerous lessons that mirrored those of the Spanish flu. Both pandemics highlighted how quickly infectious diseases can spread across boarders, which is heightened by increased global travel and trade, emphasizing the need for swift containment measures to prevent widespread propagation. Early diagnosis and contact tracing played a critical role in containing the spread of both epidemics, underscoring the importance of promptly identifying and isolating infected individuals to break the transmission chain (Rogers, 2020; Zou & Cao, 2020). Moreover, such pandemics significantly strained healthcare systems, highlighting the need for preparedness, scaling capacity, and resource allocation. Vaccination has proven as a key tool in managing epidemics, demanding for accelerated research and collaboration between scientists and regulatory organizations, as evidenced by the expeditious development of breakthrough vaccines against COVID-19 (Liang et al., 2021).
While historical epidemic experiences have shaped current responses, there are still gaps in the current outbreak control approach. The aforementioned pandemics have taught us valuable lessons about the importance of outbreak surveillance, preparedness, and the need for a comprehensive and integrated approach, such as One Health, to better address future challenges (Liang et al., 2021; Wu et al., 2022). An important aspect of the One Health approach is that it recognizes the interdependence of human, animal and environmental health. The introduction of One Health can provide a more comprehensive and proactive approach to disease prevention and control (Ahmed et al., 2023). For example, increased wildlife surveillance and surveillance for zoonotic diseases - such as COVID-19 and Spanish flu, can uncover potential risks early on (Ghai et al., 2022; Schmiege et al., 2020). Moreover, the integration of data from diverse sources enables the establishment of early warning systems, assisting authorities in identifying and addressing emerging threats before they escalate into pandemics. Moreover, One Health promotes public awareness about zoonotic infections, hygiene practices, and vaccination (World Health Organization, 2022b). Empowering communities with knowledge is crucial for taking preventive measures to reduce epidemics and protect public health. By applying the One Health principle, outbreak control can be improved, creating a safer and healthier society for everyone.
Conclusions
Throughout history, the epidemiology of infectious diseases has presented serious challenges to human health. The recent COVID-19 pandemic, as well as past outbreaks such as the Spanish flu, have underlined the critical role of outbreak surveillance and emergency response in combating these infectious threats. Early identification of epidemics and prompt response to stop further spread are made possible by surveillance systems, which function as vigilant radars that constantly search for possible threats. Diagnostic testing, contact tracing, protective measures and immunization form the basis for an effective response to outbreaks and provide essential tools for identifying, isolating and protecting against infectious agents. Implementing the One Health approach will further improve outbreak response as the interactions between human, animal and environmental health are recognized. A safer and healthier society for the future, that is better equipped to face the challenges of infectious diseases, may be built by drawing lessons from the past and adopting a collaborative and interdisciplinary approach.
Bibliographical References
Ahmed, T., Tahir, M. F., Boden, L., & Kingston, T. (2023). Future directions for One Health research: Regional and sectoral gaps. One Health, 17, 100584. https://doi.org/10.1016/j.onehlt.2023.100584
Ashby, B., & Best, A. (2021). Herd immunity. Current Biology, 31(4), R174–R177. https://doi.org/10.1016/j.cub.2021.01.006
Barrat, A., Cattuto, C., Kivelä, M., Lehmann, S., & Saramäki, J. (2021). Effect of manual and digital contact tracing on COVID-19 outbreaks: a study on empirical contact data. Journal of The Royal Society Interface, 18(178), rsif.2020.1000. https://doi.org/10.1098/rsif.2020.1000
Bohn, M. K., Lippi, G., Horvath, A., Sethi, S., Koch, D., Ferrari, M., Wang, C.-B., Mancini, N., Steele, S., & Adeli, K. (2020). Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence. Clinical Chemistry and Laboratory Medicine (CCLM), 58(7), 1037–1052. https://doi.org/10.1515/cclm-2020-0722
Bou-Karroum, L., Khabsa, J., Jabbour, M., Hilal, N., Haidar, Z., Abi Khalil, P., Khalek, R. A., Assaf, J., Honein-AbouHaidar, G., Samra, C. A., Hneiny, L., Al-Awlaqi, S., Hanefeld, J., El-Jardali, F., Akl, E. A., & El Bcheraoui, C. (2021). Public health effects of travel-related policies on the COVID-19 pandemic: A mixed-methods systematic review. Journal of Infection, 83(4), 413–423. https://doi.org/10.1016/j.jinf.2021.07.017
Budd, J., Miller, B. S., Manning, E. M., Lampos, V., Zhuang, M., Edelstein, M., Rees, G., Emery, V. C., Stevens, M. M., Keegan, N., Short, M. J., Pillay, D., Manley, E., Cox, I. J., Heymann, D., Johnson, A. M., & McKendry, R. A. (2020). Digital technologies in the public-health response to COVID-19. Nature Medicine, 26(8), 1183–1192. https://doi.org/10.1038/s41591-020-1011-4
Camero, K. (2020). Sturgis biker rally adds 267,000 COVID cases and $12.2B in health costs, report says. The Kansas City Star. https://www.kansascity.com/news/coronavirus/article245571290.html#storylink=cpy
Christensen, R., Fisher, D., Salmon, S., Drury, P., & Effler, P. (2021). Training for outbreak response through the Global Outbreak Alert and Response Network. BMC Medicine, 19(1), 123. https://doi.org/10.1186/s12916-021-01996-5
Conis, E. (2019). Measles and the Modern History of Vaccination. Public Health Reports (Washington, D.C. : 1974), 134(2), 118–125. https://doi.org/10.1177/0033354919826558
Ellwanger, J. H., Kaminski, V. de L., & Chies, J. A. B. (2019). Emerging infectious disease prevention: Where should we invest our resources and efforts? Journal of Infection and Public Health, 12(3), 313–316. https://doi.org/10.1016/j.jiph.2019.03.010
European Commission. (n.d.). Surveillance and early warning. Public Health. https://health.ec.europa.eu/health-security-and-infectious-diseases/surveillance-and-early-warning_en
Garrett, P. M., Wang, Y.-W., White, J. P., Kashima, Y., Dennis, S., & Yang, C.-T. (2022). High Acceptance of COVID-19 Tracing Technologies in Taiwan: A Nationally Representative Survey Analysis. International Journal of Environmental Research and Public Health, 19(6), 260–263. https://doi.org/10.3390/ijerph19063323
Ghai, R. R., Wallace, R. M., Kile, J. C., Shoemaker, T. R., Vieira, A. R., Negron, M. E., Shadomy, S. V., Sinclair, J. R., Goryoka, G. W., Salyer, S. J., & Barton Behravesh, C. (2022). A generalizable one health framework for the control of zoonotic diseases. Scientific Reports, 12(1), 8588. https://doi.org/10.1038/s41598-022-12619-1
Green, M. S., & Kaufman, Z. (2002). Surveillance for early detection and monitoring of infectious disease outbreaks associated with bioterrorism. The Israel Medical Association Journal : IMAJ, 4(7), 503–506. https://doi.org/12120460
Hay, A. J., & McCauley, J. W. (2018). The WHO global influenza surveillance and response system (GISRS)—A future perspective. Influenza and Other Respiratory Viruses, 12(5), 551–557. https://doi.org/10.1111/irv.12565
Hossain, A. D., Jarolimova, J., Elnaiem, A., Huang, C. X., Richterman, A., & Ivers, L. C. (2022). Effectiveness of contact tracing in the control of infectious diseases: a systematic review. The Lancet Public Health, 7(3), e259–e273. https://doi.org/10.1016/S2468-2667(22)00001-9
Howard, J., Huang, A., Li, Z., Tufekci, Z., Zdimal, V., Van Der Westhuizen, H.-M., Von Delft, A., Price, A., Fridman, L., & Tang, L.-H. (2021). An evidence review of face masks against COVID-19. Proceedings of the National Academy of Sciences, 118(4), e2014564118. https://doi.org/10.1073/pnas.2014564118
Hur, J.-Y., & Kim, K. (2020). Crisis Learning and Flattening the Curve: South Korea’s Rapid and Massive Diagnosis of the COVID-19 Infection. The American Review of Public Administration, 50(6–7), 606–613. https://doi.org/10.1177/0275074020941733
Institute of Medicine (US) Committee on Emerging Microbial Threats to Health in the 21st Century. (2003). Microbial Threats to Health: Emergence, Detection, and Response. (M. S. Smolinski, M. A. Hamburg, & J. Lederberg (eds.). https://doi.org/10.17226/10636
Jia, P., Liu, S., & Yang, S. (2023). Innovations in Public Health Surveillance for Emerging Infections. Annual Review of Public Health, 44, 55–74. https://doi.org/10.1146/annurev-publhealth-051920-093141
K.B., M., Nayar, S. A., & P.V., M. (2022). Vaccine and vaccination as a part of human life: In view of COVID‐19. Biotechnology Journal, 17(1), 2100188. https://doi.org/10.1002/biot.202100188
Kavanaugh, M. J., Azzam, S. E., & Rockabrand, D. M. (2021). Malaria Rapid Diagnostic Tests: Literary Review and Recommendation for a Quality Assurance, Quality Control Algorithm. Diagnostics (Basel, Switzerland), 11(5). https://doi.org/10.3390/diagnostics11050768
Kerrod, E., Geddes, A. M., Regan, M., & Leach, S. (2005). Surveillance and control measures during smallpox outbreaks. Emerging Infectious Diseases, 11(2), 291–297. https://doi.org/10.3201/eid1102.040609
Khan, K. (2013). Warning system for infectious diseases and method therefor. In WIPO patent WO2013120199A1. Google Patents. https://patents.google.com/patent/WO2013120199A1/en
Kubina, R., & Dziedzic, A. (2020). Molecular and Serological Tests for COVID-19. A Comparative Review of SARS-CoV-2 Coronavirus Laboratory and Point-of-Care Diagnostics. Diagnostics, 10(6), 434. https://doi.org/10.3390/diagnostics10060434
Liang, S. T., Liang, L. T., & Rosen, J. M. (2021). COVID-19: a comparison to the 1918 influenza and how we can defeat it. Postgraduate Medical Journal, 97(1147), 273–274. https://doi.org/10.1136/postgradmedj-2020-139070
Liu, L. (2021). Taiwan launches social distancing app. Taiwan News. https://www.taiwannews.com.tw/en/news/4193136
Loveday, H., & Wilson, J. (2021). Pandemic preparedness and the role of infection prevention and control - how do we learn? Journal of Infection Prevention, 22(2), 55–57. https://doi.org/10.1177/17571774211001040
Machado, B. A. S., Hodel, K. V. S., Barbosa-Júnior, V. G., Soares, M. B. P., & Badaró, R. (2020). The Main Molecular and Serological Methods for Diagnosing COVID-19: An Overview Based on the Literature. Viruses, 13(1). https://doi.org/10.3390/v13010040
Mackenzie, J. S., Drury, P., Arthur, R. R., Ryan, M. J., Grein, T., Slattery, R., Suri, S., Domingo, C. T., & Bejtullahu, A. (2014). The Global Outbreak Alert and Response Network. Global Public Health, 9(9), 1023–1039. https://doi.org/10.1080/17441692.2014.951870
McNamara, L. A., Schafer, I. J., Nolen, L. D., Gorina, Y., Redd, J. T., Lo, T., Ervin, E., Henao, O., Dahl, B. A., Morgan, O., Hersey, S., & Knust, B. (2016). Ebola Surveillance — Guinea, Liberia, and Sierra Leone. MMWR Supplements, 65(3), 35–43. https://doi.org/10.15585/mmwr.su6503a6
Moody, A. (2002). Rapid diagnostic tests for malaria parasites. Clinical Microbiology Reviews, 15(1), 66–78. https://doi.org/10.1128/CMR.15.1.66-78.2002
Murray, J., & Cohen, A. L. (2017). Infectious Disease Surveillance. In International Encyclopedia of Public Health (pp. 222–229). Elsevier. https://doi.org/10.1016/B978-0-12-803678-5.00517-8
Mykhalovskiy, E., & Weir, L. (2006). The Global Public Health Intelligence Network and early warning outbreak detection: a Canadian contribution to global public health. Canadian Journal of Public Health = Revue Canadienne de Sante Publique, 97(1), 42–44. https://doi.org/10.1007/BF03405213
Nuwarda, R. F., Ramzan, I., Weekes, L., & Kayser, V. (2022). Vaccine Hesitancy: Contemporary Issues and Historical Background. Vaccines, 10(10). https://doi.org/10.3390/vaccines10101595
Rahman, M. Z., Hoque, M. E., Alam, M. R., Rouf, M. A., Khan, S. I., Xu, H., & Ramakrishna, S. (2022). Face Masks to Combat Coronavirus (COVID-19)-Processing, Roles, Requirements, Efficacy, Risk and Sustainability. Polymers, 14(7). https://doi.org/10.3390/polym14071296
Reece, S., Brown, C. S., Dunning, J., Chand, M. A., Zambon, M. C., & Jacobs, M. (2017). The UK’s multidisciplinary response to an Ebola epidemic. Clinical Medicine (London, England), 17(4), 332–337. https://doi.org/10.7861/clinmedicine.17-4-332
Riedel, S. (2005). Edward Jenner and the history of smallpox and vaccination. Proceedings (Baylor University. Medical Center), 18(1), 21–25. https://doi.org/10.1080/08998280.2005.11928028
Rogers, K. (2020). What the 1918 flu pandemic can teach us about coronavirus. CNN Health. https://edition.cnn.com/2020/09/25/health/1918-flu-pandemic-lessons-coronavirus-wellness/index.html
Saman, S., Chauhan, I., & Srivastava, N. (2023). Vaccines: An Important Tool for Infectious Disease. Recent Advances in Anti-Infective Drug Discovery, 18(2), 88–109. https://doi.org/10.2174/2772434418666221114113036
Sarukhan, A. (2016). Ebola: Two Years and 11,300 Deaths Later. ISGlobal. https://www.isglobal.org/en/ebola
Schmiege, D., Perez Arredondo, A. M., Ntajal, J., Minetto Gellert Paris, J., Savi, M. K., Patel, K., Yasobant, S., & Falkenberg, T. (2020). One Health in the context of coronavirus outbreaks: A systematic literature review. One Health, 10, 100170. https://doi.org/10.1016/j.onehlt.2020.100170
She, J., Hou, D., Chen, C., Bi, J., & Song, Y. (2022). Challenges of vaccination and herd immunity in COVID-19 and management strategies. The Clinical Respiratory Journal, 16(11), 708–716. https://doi.org/10.1111/crj.13543
Soldano, G. J., Fraire, J. A., Finochietto, J. M., & Quiroga, R. (2021). COVID-19 mitigation by digital contact tracing and contact prevention (app-based social exposure warnings). Scientific Reports, 11(1), 14421. https://doi.org/10.1038/s41598-021-93538-5
Soucie, J. M. (2012). Public Health Surveillance and Data Collection: General Principles and Impact on Hemophilia Care. Hematology, 17(Supp 1), 144–146. https://doi.org/10.1179/102453312X13336169156537
Tang, Y.-W., Procop, G. W., & Persing, D. H. (1997). Molecular diagnostics of infectious diseases. Clinical Chemistry, 43(11), 2021–2038. https://doi.org/10.1093/clinchem/43.11.2021
Verbeek, J. H., Rajamaki, B., Ijaz, S., Sauni, R., Toomey, E., Blackwood, B., Tikka, C., Ruotsalainen, J. H., & Kilinc Balci, F. S. (2020). Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff. The Cochrane Database of Systematic Reviews, 4(4), CD011621. https://doi.org/10.1002/14651858.CD011621.pub4
Wilson, J. (2021). Infection prevention and control in the COVID-19 pandemic: what have we learnt? Journal of Infection Prevention, 22(1), 5–6. https://doi.org/10.1177/1757177420984914
Woolhouse, M. E. J., Rambaut, A., & Kellam, P. (2015). Lessons from Ebola: Improving infectious disease surveillance to inform outbreak management. Science Translational Medicine, 7(307). https://doi.org/10.1126/scitranslmed.aab0191
World Health Organization. (2014). Early detection, assessment and response to acute public health events: Implementation of Early Warning and Response with a focus on Event-Based Surveillance. Who, 1–64. https://www.who.int/publications/i/item/WHO-HSE-GCR-LYO-2014.4
World Health Organization. (2022a). Strengthening the Global Architecture for Health Emergency Preparedness, Response and Resilience. World Health Organization. https://www.who.int/publications/m/item/strengthening-the-global-architecture-for-health-emergency-prevention--preparedness--response-and-resilience
World Health Organization. (2022b). Strengthening WHO preparedness for and response to health emergencies: Strengthening collaboration on One Health Report. Eventy-Fifth World Health Assembly, 1-. https://apps.who.int/gb/ebwha/pdf_files/WHA74/A74_ACONF2-en.pdf
Wu, Q., Li, Q., & Lu, J. (2022). A One Health strategy for emerging infectious diseases based on the COVID-19 outbreak. Journal of Biosafety and Biosecurity, 4(1), 5–11. https://doi.org/10.1016/j.jobb.2021.09.003
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., Niu, P., Zhan, F., Ma, X., Wang, D., Xu, W., Wu, G., Gao, G. F., Tan, W., & China Novel Coronavirus Investigating and Research Team. (2020). A Novel Coronavirus from Patients with Pneumonia in China, 2019. The New England Journal of Medicine, 382(8), 727–733. https://doi.org/10.1056/NEJMoa2001017
Zou, X., & Cao, B. (2020). Battling COVID-19 Using Lessons Learned from 100 Years of Fighting Against Influenza. China CDC Weekly, 2(44), 867–869. https://doi.org/10.46234/ccdcw2020.230
Commentaires